Cargando…
Antiobesity Pharmacotherapy for Patients with Type 2 Diabetes: Focus on Long-Term Management
Type 2 diabetes and obesity have a complex relationship; obesity is linked to insulin resistance, the precursor to type 2 diabetes. The management of obesity is an important method to delay onset of diabetes and improve the glycemic durability of antidiabetic agents. However, insulin and some of the...
Autores principales: | Jeon, Won Seon, Park, Cheol-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285049/ https://www.ncbi.nlm.nih.gov/pubmed/25559569 http://dx.doi.org/10.3803/EnM.2014.29.4.410 |
Ejemplares similares
-
Current Long-Term Pharmacotherapies for the Management of Obesity
por: Kim, Bo-Yeon, et al.
Publicado: (2020) -
An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
por: Enright, Connor, et al.
Publicado: (2023) -
Antihyperglycemic and Antiobesity Effects of JAL2 on db/db Mice
por: Lee, In-Seung, et al.
Publicado: (2016) -
Cardiovascular Pharmacotherapy Focus
por: Avanzas, Pablo
Publicado: (2019) -
Preventive pharmacotherapy in type 2 diabetes mellitus
por: Choudhary, Neeraj, et al.
Publicado: (2012)